Wednesday , 6 November 2024
Home Health SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition
Health

SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition

SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition

Securities regulators say the role of Ipsen employee Dishant Gupta made him privy to details of the Epizyme acquisition. Gupta allegedly accumulated Epizyme shares while the deal was negotiated, then sold all of them hours after the transaction was announced.

The post SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition appeared first on MedCity News.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Heat-related illnesses are preventable; here’s how

By PHIYEN NGUYEN & KRISTINA CARVALHO As we enjoy the crisp air...

WTW: There’s A Disconnect Between Employers and Employees on Wellbeing Programs

Employers are prioritizing mental wellbeing programs, but employees say they need financial...

Best hospital for Congenital Hip Dislocation Treatment

Developmental dysplasia of the hip, also known as congenital hip dislocation, is...